HIV-1 Suppression by MHC class I restricted CD8 T Cells
HIV-1 Suppression by MHC class I restricted CD8 T Cells
批准号:
7282233
负责人:
Paul A. Goepfert
金额:
$21.75万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-05 至 2009-04-30
关键词:
Animal ModelAntigensBiological AssayCD8B1 geneCell SeparationCellsChromiumClinical MarkersCommunicable DiseasesCytoplasmic GranulesDataDetectionDisease ProgressionEpitopesExhibitsFlow CytometryGenesGoalsHIVHIV-1ImmuneImmune responseIn VitroIndividualInfectionInterferonsLeadLinkMHC Class I GenesMeasuresMemoryMethodsPeripheral Blood Mononuclear CellPhenotypePlasmaPolymerase Chain ReactionPopulationPrincipal InvestigatorRadioisotopesReagentRelative (related person)ResearchRoleSorting - Cell MovementSurfaceSurrogate MarkersT-Cell ReceptorT-LymphocyteT-Lymphocyte EpitopesTNF geneTRB@ gene clusterTechnologyTestingTimeVaccine DesignVaccinesViralViral Load resultVirusantiretroviral therapybasebeta Chain Antigen T Cell Receptorcell killingchemokinecytokinecytotoxicdesignin vivokillingspathogenprogramsresearch studyresponsestem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): While animal model studies point to the importance of CD8 T cell responses in controlling HIV-1 replication, the specific quality of these cells achieving this control are unknown. Numerous studies have attempted to correlate different parameters of HIV-1 specific CD8 T cells with clinical markers of disease progression; however, inconsistent data has been attained. Also, for the studies that have seen correlations with plasma viral load, it is unclear whether the observed CD8 T cells parameter are just the result of low viral replication rather than a causative factor in controlling this replication. The problem stems from the fact that most assays do not measure the actual function of CD8 T cells in controlling HIV-1 but instead measure potential surrogate markers of this control. Specific Aim 1 of our proposal will analyze the efficiency of HIV-1 CD8 T cell clones in killing and suppressing HIV-1 replication using in vitro viral assays. Every clone will be identified on the basis T cell receptor ¿ gene (TCRB) sequencing. Using polychromatic flow cytometry in specific aim 2, we will sort HIV-1 specific CD8 T cells according to their capacity to express combinations of 4 different functional parameters (IFN-?, IL-2, TNF-a, and CD107). We will then determine which of the specific populations of HIV-1 CD8 T cells is enriched with clones that efficiently control virus in vitro. Our findings will have important implications fro HIV immunopathogenesis and vaccine design by supplying an HIV-1 specific CD8 T cell phenotype that results in efficient HIV-1 control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of HIV adaptation to CD8 T cells on infection and viral control
-
批准号:10245517
-
项目类别:
-
资助金额:$66.21万
-
财政年份:2020
-
负责人:Paul A. Goepfert
-
依托单位:
Defining the biological relevance of HIV-1 adaptation to CD4 T cell responses
-
批准号:9418347
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2017
-
负责人:Paul A. Goepfert
-
依托单位:
Defining the biological relevance of HIV-1 adaptation to CD4 T cell responses
-
批准号:10186453
-
项目类别:
-
资助金额:$62.81万
-
财政年份:2017
-
负责人:Paul A. Goepfert
-
依托单位:
A Rational Approach for HIV Vaccine T Cell Epitope Selection
-
批准号:8797988
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2014
-
负责人:Paul A. Goepfert
-
依托单位:
A Rational Approach for HIV Vaccine T Cell Epitope Selection
-
批准号:9087090
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2014
-
负责人:Paul A. Goepfert
-
依托单位:
A Rational Approach for HIV Vaccine T Cell Epitope Selection
-
批准号:8892071
-
项目类别:
-
资助金额:$46.26万
-
财政年份:2014
-
负责人:Paul A. Goepfert
-
依托单位:
A Rational Approach for HIV Vaccine T Cell Epitope Selection
-
批准号:9302653
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2014
-
负责人:Paul A. Goepfert
-
依托单位:
Analysis of Variant Epitope Specific CD8 T-Cells to Optimize HIV Vaccine Design
-
批准号:8546018
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2012
-
负责人:Paul A. Goepfert
-
依托单位:
CTL and HIV Polymorphisms in Heterosexual Transmission
-
批准号:8069728
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2010
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
-
批准号:8131729
-
项目类别:
-
资助金额:$50.19万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
Clinical
-
批准号:7685017
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
-
批准号:7928730
-
项目类别:
-
资助金额:$51.71万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
-
批准号:8319514
-
项目类别:
-
资助金额:$50.04万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
-
批准号:8526357
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
-
批准号:7760837
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2009
-
负责人:Paul A. Goepfert
-
依托单位:
Clinical
-
批准号:7697006
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2008
-
负责人:Paul A. Goepfert
-
依托单位:
A-Z Clinical Trials Unit
-
批准号:10528462
-
项目类别:
-
资助金额:$186.27万
-
财政年份:2007
-
负责人:Paul A. Goepfert
-
依托单位:
HIV-1 Suppression by MHC class I restricted CD8 T Cells
-
批准号:7416726
-
项目类别:
-
资助金额:$17.78万
-
财政年份:2007
-
负责人:Paul A. Goepfert
-
依托单位:
A-Z Clinical Trials Unit
-
批准号:10305654
-
项目类别:
-
资助金额:$189.98万
-
财政年份:2007
-
负责人:Paul A. Goepfert
-
依托单位:
CTL and HIV Polymorphisms in Heterosexual Transmission
-
批准号:8449667
-
项目类别:
-
资助金额:$134.07万
-
财政年份:2005
-
负责人:Paul A. Goepfert
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: